A highly amyloidogenic region of hen lysozyme

Journal of Molecular Biology

Volumn 340, Issue 5, 2004, Pages 1153-1165

  Frare, Erica ^a   Polverino De Laureto, Patrizia ^a   Zurdo, Jesús ^b   Dobson, Christopher M ^b   Fontana, Angelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

amyloid fibrils; fragment 57 107, a fragment of HEWL cross linked by the two disulfide bridges Cys64 Cys80 and Cys76 Cys94; HEWL, hen egg white lysozyme; limited proteolysis; lysozyme; protein domains; protein fragments

Indexed keywords

AMYLOID; ASPARTIC ACID; CYSTEINE; DISULFIDE; LYSOZYME; PEPSIN A; POLYPEPTIDE;

ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; HEN; HYDROLYSIS; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN STRUCTURE; STATISTICAL SIGNIFICANCE;

EID: 3042673992     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.05.056     Document Type: Article

References (68)

1. Wetzel, R. (1999). Editor of Amyloids, Prions and Other Protein Aggregates. Methods in Enzymology, vol 39, Academic Press, San Diego, CA.
2. Selkoe D.J. Folding proteins in fatal ways. Nature. 426:2003;900-904
3. Cohen F.E., Kelly J.W. Therapeutic approaches to protein-misfolding diseases. Nature. 426:2003;905-909
4. Stefani M., Dobson C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81:2003;678-699
5. Dobson C.M. Protein folding and disease: a view from the first Horizon symposium. Nature Rev. Drug Discov. 2:2003;154-160
6. Dobson C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24:1999;329-332
7. Sacchettini J.C., Kelly J.W. Therapeutic strategies for human amyloid diseases. Nature Rev. Drug Discov. 4:2002;267-275
8. Fink A. Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold. Des. 3:1998;R9-R23
9. Pepys M.B., Hawkins P.N., Booth D.R., Vigushin D.M., Tennent G.A., Soutar A.K., et al. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature. 362:1993;553-557
10. Valleix S., Drunat S., Philit J.B., Adoue D., Piette J.C., Droz D., et al. Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family. Kidney Int. 61:2002;907-912
11. Yazaki M., Farrell S.A., Benson M.D. A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis. Kidney Int. 63:2003;1652-1657
12. Hawkins P.N. Hereditary systemic amyloidosis with renal involvement. J. Nephrol. 16:2003;443-448
13. Funahashi J., Takano K., Ogasahara K., Yamagata Y., Yutani K. The structure, stability, and folding process of amyloidogenic mutant human lysozyme. J. Biochem. 120:1996;1216-1223
14. Booth D.R., Sunde M., Bellotti V., Robinson C.V., Hutchinson W.L., Fraser P.E., et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature. 385:1997;787-797
15. Canet D., Sunde M., Last A.M., Miranker A., Spencer A., Robinson C.V., Dobson C.M. Mechanistic studies of the folding of human lysozyme and the origin of the amyloidogenic behavior in its disease-related variants. Biochemistry. 38:1999;6419-6427
16. Canet D., Last A.M., Tito P., Sunde M., Spencer A., Arche D.B., et al. Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme. Nature Struct. Biol. 9:2002;308-314
17. Dumoulin M., Last A.M., Desmyter A., Decanniere K., Canet D., Larsson G., et al. A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature. 424:2003;783-788
18. Morozova-Roche L.A., Zurdo J., Spencer A., Noppe W., Receveur V., Archer D.B., et al. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. J. Struct. Biol. 130:2000;339-351
19. Krebs M.R., Wilkins D.K., Chung E.W., Pitkeathly M.C., Chamberlain A.K., Zurdo J., et al. Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. J. Mol. Biol. 300:2000;541-549
20. Goda S., Takano K., Yamagata Y., Nagata R., Akutsu H., Maki S., et al. Amyloid protofilament formation of hen egg lysozyme in highly concentrated ethanol solution. Protein Sci. 9:2000;369-375
21. Cao A., Hu D., Lai L. Formation of amyloid fibrils from fully reduced hen egg white lysozyme. Protein Sci. 13:2004;319-324
22. Goers J., Permyakov S.E., Permyakov E.A., Uversky V.N., Fink A. Conformational prerequisites for α-lactalbumin fibrillation. Biochemistry. 41:2002;12546-12551
23. Fontana A., Polverino de Laureto P., De Filippis V., Scaramella E., Zambonin M. Probing the partly folded states of proteins by limited proteolysis. Fold. Des. 2:1997;R17-R26
24. Fontana A., Zambonin M., Polverino de Laureto P., De Filippis V., Clementi A., Scaramella E. Probing the conformational state of apomyoglobin by limited proteolysis. J. Mol. Biol. 266:1997;223-230
25. Fontana A., Polverino de Laureto P., De Filippis V., Scaramella E., Zambonin M. Limited proteolysis in the study of protein conformation. Sterchi E.E., Stöcker W. Proteolytic Enzymes: Tools and Targets. 1999;257-284 Springer, Heidelberg
26. Polverino de Laureto P., Scaramella E., Frigo M., Gefter-Wondrich F., De Filippis V., Zambonin M., Fontana A. Limited proteolysis of bovine α-lactalbumin: isolation and characterization of protein domains. Protein Sci. 8:1999;2290-2303
27. Polverino de Laureto P., Frare E., Gottardo R., Van Dael H., Fontana A. Partly folded states of members of the lysozyme/lactalbumin superfamily: a comparative study by circular dichroism spectroscopy and limited proteolysis. Protein Sci. 11:2002;2932-2946
28. LeVine H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2:1993;404-410
29. Schultz J. Cleavage at aspartic acid. Methods Enzymol. 11:1967;255-263
30. Inglis A.S. Cleavage at aspartic acid. Methods Enzymol. 91:1983;324-332
31. Tomizawa H., Yamada H., Ueda T., Imoto T. Isolation and characterization of 101-succinimide lysozyme that possesses the cyclic imide at Asp101-Gly102. Biochemistry. 33:1994;8770-8774
32. Sasahara K., Demura M., Nitta K. Partially unfolded equilibrium state of hen lysozyme studied by circular dichroism spectroscopy. Biochemistry. 39:2000;6475-6482
33. Fruton J.S. The specificity and mechanism of pepsin action. Advan. Enzymol. 33:1970;401-443
34. Yang J.J., Pitkeathly M., Radford S.E. Far-UV circular dichroism reveal a conformational switch from the beta-sheet of hen lysozyme. Biochemistry. 33:1994;7345-7353
35. Chen Y.H., Yang J.T., Chau K.H. Determination of the helix and β form of proteins in aqueous solution by circular dichroism. Biochemistry. 13:1974;3350-3359
36. Johnson W.C. Jr. Protein secondary structure and circular dichroism: a practical guide. Proteins: Struct. Funct. Genet. 7:1990;205-214
37. Strickland E.H. Aromatic contribution to circular dichroism spectra of proteins. CRC Crit. Rev. Biochem. 5:1974;113-175
38. Woody R.W. Circular dichroism. Methods Enzymol. 246:1995;34-71
39. Kelly S.M., Price N.C. The application of circular dichroism to study of protein folding and unfolding. Biochim. Biophys. Acta. 1338:1997;161-185
40. Sunde M., Blake C.C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Advan. Protein Chem. 50:1997;123-159
41. Fontana A., Gross E. Fragmentation of polypeptides by chemical methods. Darbre A. Pratical Protein Chemistry: A Handbook. 1986;67-120 Wiley, New York
42. Li A., Sowder R.C., Moore S.P., Garfinkel D.J., Fisher R.J. Chemical cleavage at aspartyl residues for protein identificatin. Anal. Chem. 73:2001;5395-5402
43. Malisauskas M., Zamotin V., Jass J., Noppe W., Dobson C.M., Morozova-Roche L.A. Amyloid protofilaments from the calcium-binding protein equine lysozyme: formation of ring and linear structures depends on pH and metal ion concentration. J. Mol. Biol. 330:2003;879-890
44. Hooke S.D., Radford S.E., Dobson C.M. The refolding of human lysozyme: a comparison with the structurally homologous hen lysozyme. Biochemistry. 33:1994;5867-5876
45. Chiti F., Stefani M., Taddei N., Ramponi G., Dobson C.M. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature. 424:2003;805-808
46. Dubay, K. F., Pawar, A., Chiti, F., Zurdo, J., Dobson, C. M. & Vendruscolo, M. (2004). Predicting absolute aggregation rates of amyloidogenic polypeptide chains. J. Mol. Biol., in press.
47. Fontana A., Fassina G., Vita C., Dalzoppo D., Zamai M., Zambonin M. Correlation between sites of limited proteolysis and segmental mobility in thermolysin. Biochemistry. 25:1986;1847-1851
48. Miranker A., Radford S.E., Karplus M., Dobson C.M. Demonstration by NMR of folding domains in lysozyme. Nature. 349:1991;633-636
49. Radford S.E., Dobson C.M., Evans P.A. The folding of hen lysozyme involves partially structured intermediates and multiple pathways. Nature. 358:1992;302-307
50. Dobson C.M., Evans P.A., Radford S.E. Understanding how proteins fold: the lysozyme story so far. Trends Biochem. Sci. 19:1994;31-37
51. Polverino de Laureto P., Donadi M., Scaramella E., Frare E., Fontana A. Trifluoroethanol-assisted protein folding: fragment 53-103 of bovine alpha-lactalbumin. Biochim. Biophys. Acta. 1548:2001;29-37
52. Ueda T., Ohkuri T., Imoto T. Identification of the peptide region that folds into a native conformation in the early stage of the renaturation of reduced lysozyme. Biochem. Biophys. Res. Commun. 228:1996;203-208
53. Muñoz V., Serrano L. Elucidating the folding problem of helical peptides using empirical parameters. Nature Struct. Biol. 1:1994;399-409
54. Yang J.J., Buck M., Pitkeathly M., Kotik M., Haynie D.T., Dobson C.M., Radford S.E. Conformational properties of four peptides spanning the sequence of hen lysozyme. J. Mol. Biol. 252:1995;483-491
55. Villegas V., Zurdo J., Filimonov V.V., Aviles F.X., Dobson C.M., Serrano L. Protein engineering as a strategy to avoid formation of amyloid fibrils. Protein Sci. 9:2000;1700-1708
56. Kallberg Y., Gustafsson M., Persson B., Thyberg J., Johansson J. Prediction of amyloid fibril-forming proteins. J. Biol. Chem. 276:2001;12945-12950
57. Esposito G., Garcia J., Mangione P., Giorgetti S., Corazza A., Viglino P., et al. Structural and folding dynamic properties of the T70N variant of human lysozyme. J. Biol. Chem. 278:2003;25910-25918
58. Orpiszewski J., Schormann N., Kluve-Beckerman B., Liepnieks J.J., Benson M.D. Protein aging hypothesis of Alzheimer disease. FASEB J. 14:2000;1255-1263
59. Clarke S. Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins. Int. J. Pept. Protein Res. 30:1987;808-821
60. Lindner H., Helliger W. Age-dependent deamidation of asparagine residues in proteins. Expt. Gerontol. 36:2001;1551-1563
61. Shapira R., Austin G.E., Mirra S.S. Neuritic plaque amyloid in Alzheimer's disease is highly racemized. J. Neurochem. 50:1988;69-74
62. Roher A.E., Lowenson J.D., Clarke S., Woods A.S., Cotter R.J., Gowing E., Ball M.J. Beta-amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer's disease. Proc. Natl Acad. Sci. USA. 90:1993;10836-10840
63. Roher A.E., Lowenson J.D., Clarke S., Wolkow C., Wang R., Cotter R.J., et al. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268:1993;3072-3083
64. Weber D.J., McFadden P.N., Caughey B. Measurement of altered aspartyl residues in the scrapie associated form of prion protein. Biochem. Biophys. Res. Commun. 246:1998;606-608
65. Lopez de la Paz M., Goldie K., Zurdo J., Lacroix E., Dobson C.M., Hoenger A., Serrano L. De novo designed peptide-based amyloid fibrils. Proc. Natl Acad. Sci. USA. 99:2002;16052-16057
66. Gill S.G., von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:1989;319-326
67. Blake C.C.F., Koenig D.F., Mair G.A., North A.C.T., Philips D.C., Sarma V.R. Structure of hen egg-white lysozyme. Nature. 206:1965;757-761
68. Canfield R.E. The amino acid sequence of egg-white lysozyme. J. Biol. Chem. 238:1963;2698-2707